| Serial Number | 99204276 |
| Word Mark | CELL STATE SWITCHING |
| Filing Date | Tuesday, May 27, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development of new products in the nature of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of medicine and diagnostic testing featuring pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and research; scientific research in the field of drug discovery and development; biomedical research services; pharmaceutical drug development services, namely, preclinical development of therapeutic products; bioinformatic services in the nature of scientific research, namely, collecting and analyzing complex biological data through the use of artificial intelligence; providing temporary use of non-downloadable artificial intelligence (AI) computer software for molecular design in the fields of pharmaceutical research, medicine, and diagnostic testing for disease; scientific diagnostic and screening services for scientific research purposes, namely, conducting scientific diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combating of diseases; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development; providing on-line non-downloadable artificial intelligence (AI) software for the capture, collection, conversion, analysis, transmission, processing, receiving, recording, storage and transmission of data, images, information in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable artificial intelligence (AI) software featuring machine learning for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks in the field of scientific research; medical research services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combating of diseases |
| Goods and Services | Medical diagnostic and screening services in the fields of medicine, diagnostic testing, molecular evaluation, and combating of diseases utilizing artificial intelligence and molecular research |
| Goods and Services | Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 27, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 27, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cellarity, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 US |
| Event Date | Event Description |
| Tuesday, May 27, 2025 | NEW APPLICATION ENTERED |
| Tuesday, May 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 27, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 15, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, October 15, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 15, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 6, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, January 6, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, April 14, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 14, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 14, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |